Diabetes 'increases head and neck cancer risk'

25 July 2014

People suffering from diabetes mellitus (DM) are at an increased risk of head and neck cancer, new evidence from Taiwan's Tainan University of Technology suggests.

Head and neck cancer is the sixth most common type of cancer, accounting for around six per cent of all cases, with an estimated 650,000 new diagnoses worldwide each year.

Although certain cancers are more common in people with DM, the risk of head and neck cancer in patients with DM had not been well explored, until the new Taiwan study, which used the country's Longitudinal Health Insurance Research Database as its basis.

The report authors found that the incidence of head and neck cancer was 1.47 times higher in patients newly diagnosed with DM, with cancer in the oral cavity having the highest incidence rate, at 0.41 per cent.

Lead study author Dr Kuo-Shu Tseng commented: "Because we adequately controlled for the confounding factors, our findings disclose a higher incidence of HNC in patients with DM and highlight the importance of monitoring patients with DM for HNC."

Posted by Edward Bartel

 

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)